In spite of the primary tumor size, the NSCLC patients with high Id1 expression showed a better survival rate than the patients with low Id1 expression after the adjuvant chemotherapy (Figure 4), suggesting that Id1 predicts a favorable prognosis under the specified treatment condition. The gene discussed is ID1; the disease is non-small cell lung carcinoma.